Pimavanserin
98%
- Product Code: 124797
CAS:
706779-91-1
| Molecular Weight: | 427.5548 g./mol | Molecular Formula: | C₂₅H₃₄FN₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 604.222℃ at 760 mmHg | |
| Density: | 1.15g/ml | Storage Condition: | -20℃ |
Product Description:
Pimavanserin is primarily used in the treatment of Parkinson’s disease psychosis (PDP), a condition where individuals experience hallucinations and delusions. It works as a selective serotonin inverse agonist, specifically targeting serotonin 5-HT2A receptors, which helps reduce psychotic symptoms without worsening motor function. This makes it a valuable option for patients with Parkinson’s, as it avoids the side effects associated with traditional antipsychotics. Additionally, it has been explored for potential use in other psychiatric conditions, such as Alzheimer’s disease-related psychosis and major depressive disorder, though these applications are still under investigation. Its unique mechanism of action offers a targeted approach to managing psychosis in vulnerable patient populations.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 97.5-100 |
| 1 H NMR Spectrum | Consistent With Structure |
| LCMS | Consistent With Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $26.70 |
+
-
|
| 0.050 | 10-20 days | $86.41 |
+
-
|
| 0.250 | 10-20 days | $299.43 |
+
-
|
Pimavanserin
Pimavanserin is primarily used in the treatment of Parkinson’s disease psychosis (PDP), a condition where individuals experience hallucinations and delusions. It works as a selective serotonin inverse agonist, specifically targeting serotonin 5-HT2A receptors, which helps reduce psychotic symptoms without worsening motor function. This makes it a valuable option for patients with Parkinson’s, as it avoids the side effects associated with traditional antipsychotics. Additionally, it has been explored for potential use in other psychiatric conditions, such as Alzheimer’s disease-related psychosis and major depressive disorder, though these applications are still under investigation. Its unique mechanism of action offers a targeted approach to managing psychosis in vulnerable patient populations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :